5 Investors to Follow Other Than Warren Buffett
There is no doubt that Warren Buffett is one of…
Sell
40
BEAM Quote, Financials, Valuation and Earnings
Last price:
$17.23
Seasonality move
:
29.84%
Day range:
$15.64 - $17.75
52-week range:
$13.53 - $35.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
21.41x
P/B ratio:
1.45x
Volume:
2.6M
Avg. volume:
2.7M
1-year change:
-22.44%
Market cap:
$1.6B
Revenue:
$63.5M
EPS (TTM):
-$4.61
BEAM Analysts' Consensus Rating
The 13 analysts providing 12-month price projections for Beam Therapeutics shares anticipate an average target of $45.00, ranging from a low estimate of $20.00 to a high estimate of $80.00. This average target implies a growth of 177.35% compared to the current stock price of $16.23.
Consensus Price Target
$45.00
Highest Price Target
$80.00
Lowest Price Target
$20.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 7 | 10 | 10 |
| Hold | 8 | 3 | 3 |
| Sell | 0 | 0 | 0 |
| Consensus | Hold | Buy | Buy |
BEAM Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is BYD a Threat To Tesla Shareholders?
BYD (OTC:BYDDY) has rocketed to the top of China’s booming…
CVX Vs XOM Stock, Which Energy Play Is Best?
Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Buy
60
RGC alert for May 8
Regencell Bioscience Holdings [RGC] is up 10.54% over the past day.
Buy
92
TPB alert for May 8
Turning Point Brands [TPB] is down 6.67% over the past day.
Buy
74
LIVN alert for May 8
LivaNova PLC [LIVN] is up 1.33% over the past day.
